Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001422849-25-000077
Filing Date
2025-11-13
Accepted
2025-11-13 19:06:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5735
  Complete submission text file 0001422849-25-000077.txt   7513
Mailing Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071 213-486-9200
Capital World Investors (Filed by) CIK: 0001422849 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G/A

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Subject) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93833 | Film No.: 251480400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)